WHO ICTRP trial
Tanshinone, metformin, or their combination for insulin resistance in women with…
ChiCTR2000035680 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000035680 |
|---|---|
| Public title | Tanshinone, metformin, or their combination for insulin resistance in women with polycystic ovarian syndrome: a double blind randomised controlled trial |
| Scientific title | Tanshinone, metformin, or their combination for insulin resistance in women with polycystic ovarian syndrome: a double blind randomised controlled trial |
| Primary sponsor | Shanghai Traditional Chinese Medicine Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | polycystic ovarian syndrome |
| Interventions | Metformin group :Metformin and Tanshinone placebo;Tanshinone:Tanshinone and Metformin palcebo;Tanshinone and Metformin group:Tanshinone and Metformin;placebo group:Tanshinone placebo and Metformin placebo |
| Registration date | Aug 16, 2020 |
| Target size | Metformin group :84;Tanshinone:84;Tanshinone and Metformin group:84;placebo… |
| Secondary IDs | ChiMCTR2000003582 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: